サーベイランスのためのCDCガイドライン　改訂5版

出版社： メディカ出版
著者：
発行日： 2012-05-05
分野： 臨床医学：内科  >  感染症/AIDS
ISBN： 9784840440271
電子書籍版： 2015-04-01 （電子書籍版）
書籍・雑誌
≪全国送料無料でお届け≫
品切れ

3,740 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

3,740 円(税込)

購入する

商品紹介

病院感染対策上重要な、サーベイランス実施の指針となる担当者必携の1冊。改訂5版ではBSI・UTI・SSIの疾患定義とリスク因子調整法の更新に加え、多剤耐性病原体、C.difficile感染のサーベイランスも盛り込まれ、より内容が充実。

目次

  • サーベイランスのためのCDCガイドライン　改訂5版

    ―目次―

    I　アメリカ合衆国における医療関連感染サーベイランスの歴史

    II　NHSNとは〜イントロダクション

    III　NHSNにおける3つの部門
    　A．NHSNとその3つの部門
    　B．サーベイランスの技術
    　C．手技関連モジュール
    　D．デバイス関連モジュール
    　E．薬剤関連モジュール
    　F．多剤耐性病原体／C. difficile感染モジュール（MDRO／
    　　　CDIモジュール）
    　G．ワクチン接種モジュール

    IV　患者安全部門
    　A．NHSNにおけるHAIの同定
    　B．患者安全月間報告計画
    　C．デバイス関連モジュール
    　　1 中心ライン関連血流感染（CLABSI）
    　　2 中心ライン挿入実務遵守（CLIP）モニタリング
    　　3 人工呼吸器関連肺炎（VAP）
    　　4 カテーテル関連尿路感染（CAUTI）
    　　5 透析イベント（DE）
    　D．手技関連モジュール
    　　1 手術部位感染（SSI）イベント
    　　2 手技後肺炎（PPE）
    　E．薬剤関連モジュール
    　　1 抗菌薬の使用と耐性（AUR）オプション
    　F．MDRO／CDIモジュール
    　　1 MDROオプション
    　　2 C. difficile（CDI）オプション
    　G．ワクチン接種モジュール
    　H．NHSNで用いられる用語の定義

    V　医療従事者安全部門

おすすめ商品

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

IV 患者安全部門

P.50 掲載の参考文献
1) Klevens, RM. et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Reports. 122, 2007, 160-6.
PubMed
2) O'Grady, NP. et al. Guidelines for the prevention of intravascular catheter-related infections, 2011. Clinical Infectious Diseases. 52(a), 2011, 1087-99.
PubMed
3) Clinical and Laboratory Standards Institute (CLSI). Principles and Procedures for Blood Cultures ; Approved Guideline. CLSI document M47-A (ISBN 1-56238-641-7). Pennsylvania, Clinical and Laboratory Standards Institute, USA, 2007.
 
4) Baron, EJ. et al. Blood Cultures IV. Washington, DC, ASM Press, 2005.
 
P.56 掲載の参考文献
1) O'Grady, NP. et al. Guidelines for the prevention of intravascular catheter-related infections, 2011. Clinical Infectious Diseases. 52(a), 2011, 1087-99.
PubMed
P.74 掲載の参考文献
1) Klevens, RM. et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Reports. 122, 2007, 160-6.
PubMed
2) Centers for Disease Control and Prevention. Guidelines for preventing health-care-associated pneumonia, 2003 : recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR. 53(No. RR-3), 2004.
 
P.87 掲載の参考文献
1) Klevens, RM. et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Reports. 122, 2007, 160-6.
PubMed
2) Gould, CV. et al. Guideline for prevention of catheter-associated urinary tract infections 2009. Infect Control Hosp Epidemiol. 31(4), 2010, 319-26.
PubMed
P.97 掲載の参考文献
1) U.S. Renal Data System. USRDS 2009 Annual Data Report : Atlas of End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2009. (http://www.usrds.org/adr.htm)
 
2) Klevens, RM. et al. Dialysis Surveillance Report : national Healthcare Safety Network (NHSN) -data summary for 2006. Seminars in Dialysis. 21(1), 2008, 24-8.
PubMed
3) Kessler, M. et al. Bacteremia in patients on chronic hemodialysis. Nephron. 64, 1993, 95-100.
PubMed
4) Stevenson, KB. et al. Standardized surveillance of hemodialysis vascular access infections : 18-month experience at an outpatient, multicenter hemodialysis center. Infect Control Hosp Epidemiol. 21, 2000, 200-3.
 
5) Tokars, JI. et al. A prospective study of vascular access infections at seven outpatient hemodialysis centers. Am J Kidney Dis. 37, 2001, 1232-40.
PubMed
6) Kaplowitz, LG. et al. A prospective study of infections in hemodialysis patients : patient hygiene and other risk factors for infection. Infect Control Hosp Epidemiol. 9, 1988, 534-41.
PubMed
7) Tokars, J. et al, the Dialysis Surveillance Network. The influence of blood culture frequency on reported bactermia in hemodialysis outpatients. Abstract presented at the Society for Healthcare Epidemiology of America, Salt Lake City, UT, April 2002.
 
P.135 掲載の参考文献
1) Klevens, RM. et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Reports. 122, 2007, 160-6.
PubMed
2) Emori, TG. et al. An overview of healthcare-associated infections, including the role of the microbiology laboratory. Clin Microbiol Rev. 6(4), 1993, 428-42.
 
3) Condon, RE. et al. Effectiveness of a surgical wound surveillance program. Arch Surg. 118, 1983, 303-7.
PubMed
4) Society for Healthcare Epidemiology of America, Association for Professionals in Infection Control and Epidemiology, Centers for Disease Control and Prevention, Surgical Infection Society. Consensus paper on the surveillance of surgical wound infections. Infect Control Hosp Epidemiol. 13(10), 1992, 599-605.
 
5) Haley, RW. et al. The efficacy of infection surveillance and control programs in preventing healthcare-associated infections in US hospitals. Am J Epidemiol. 121, 1985, 182-205.
PubMed
6) Centers for Disease Control and Prevention. Guideline for prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol. 20(4), 1999, 247-78.
 
7) Facilities Guidelines Institute. Guidelines for design and construction of health care facilities. Chicago, American Society for Healthcare Engineering, 2010.
 
P.138 掲載の参考文献
1) Celis, R. et al. Healthcare-associated pneumonia : a multivariate analysis of risk and prognosis. Chest. 93, 1988, 318-24.
 
2) Hooton, TM. et al. The joint association of multiple risk factors with the occurrence of healthcare-associated infection. Am J Med. 70, 1981, 960-70.
PubMed
3) Windsor, JA. et al. Risk factors for postoperative pneumonia : the importance of protein depletion. Am Surg. 208, 1988, 209-14.
 
4) Horan, TC. et al. and the National Healthcare-associated Infections Surveillance (NNIS) System. Healthcare-associated infections in surgical patients in the United States, January 1986-June 1992. Infect Control Hosp Epidemiol. 14, 1993, 73-80.
 
P.145 掲載の参考文献
1) Hidron, AI. et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections : annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol. 29, 2008, 996-1011.
 
2) Schwartz, MN. Use of antimicrobial agents and drug resistance. N Eng J Med. 337, 1997, 491-2.
 
3) Ansari, F. et al. Outcomes of an intervention to improve hospital antibiotic prescribing ; interrupted time series with segmented regression analysis. J Antimicrob Chemother. 52, 2003, 842-8.
PubMed
4) Solomon, DH. et al. Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center. Arch Inter Med. 161, 2001, 1897-902.
 
5) Fraser, GL. et al. Antibiotic optimizations : an evaluation of patient safety and economic outcomes. Arch Inter Med. 157, 1997, 1689-94.
 
6) Dellit, TH. et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship. Clin Infect Dis. 44, 2007, 159-77.
 
7) National Healthcare Safety Network (NHSN) Patient Safety Component : Clinical Document Architecture. www.cdc.gov/nhsn/CDA_eSurveillance.html
 
8) Schwartz, DN. et al. Deriving measures of intensive care unit antimicrobial use from computerized pharmacy data : methods, validation, and overcoming barriers. Infect Control Hosp Epidemiol. 32, 2011, 472-80.
PubMed
9) Polk, RE. et al. Measurement of adult Antibacterial Drug Use in 130 US Hospitals : Comparison of Defined Daily Dose and Days of Therapy. Clin Infect Dis. 44, 2007, 664-70.
PubMed
10) Kuster, SP. et al. Quantitative antibiotic use in hospitals : comparison of measurements, literature review, and recommendations for standards of reporting. Infection. 6, 2008, 549-59.
PubMed
11) Berrington, A. Antimicrobial prescribing in hospitals : be careful what you measure. J Antimicrob Chemother. 65, 2010, 163-8.
PubMed
12) Cohen, AL. et al. Recommendations for metrics for multidrug-resistant organisms in healthcare settings : SHEA/HICPAC position paper. Infect Control Hosp Epidemiol. 29, 2008, 901-13.
PubMed
P.185 掲載の参考文献
1) http://www.cdc.gov/ncidod/dhqp/pdf/ar/mdroGuideline2006.pdf
 
2) Cohen, AL. et al. Recommendations for Metrics for Multidrug-Resistant Organisms in Healthcare Settings : SHEA/HICPAC Position Paper. Infect Control Hosp Epidemiol 29, 2008, 901-13.
PubMed
3) McDonald, LC. et al. Recommendations for Surveillance of Clostridium difficile-Associated Disease. Infect Control Hosp Epidemiol. 28, 2007, 140-5.
PubMed
P.201 掲載の参考文献
1) Anonymous. New classification of physical status. Anesthesiology. 24, 1963, 111.
 
2) American Academy of PediatricsPolicy Statement : Levels of neonatal care. Pediatrics. 114(5), 2004, 1341-7.
 
3) Facilities Guidelines Institute. Guidelines for design and construction of health care facilities. Chicago, American Society for Healthcare Engineering, 2010.
 
4) Mangram, AJ. and the Hospital Infection Control Practices Advisory Committee. Guideline for prevention of surgical site infection 1999. Infect Control Hosp Epidemiol. 20, 1999, 247-80.
 

書評

最近チェックした商品履歴

Loading...